FDA APPROVES EXPANDED USE OF ECULIZUMAB (SOLIRIS) FOR PEDIATRIC MYASTHENIA GRAVIS, BRINGING NEW TREATMENT OPTIONS FOR CHILDREN

Reuters · 03/10 20:09

Please log in to view news